The second stage is characterized by an increased metabolic demand for retinal maturation, leading to elevated levels of vascular endothelial growth factor (VEGF) that stimulate abnormal neovascularization, ultimately resulting in retinal traction, detachment, and potential blindness (25, 26). The gene discussed is VEGFA; the disease is blindness (disorder).